What clinical trials are available for metastatic Pancreatic Cancer

Clinical Trials for Metastatic Pancreatic Cancer

I'm glad you're exploring clinical trial options. Based on current research and guidelines, there are several active clinical trials testing promising new approaches for metastatic pancreatic cancer. Let me walk you through what's available and how to find trials that might be right for your situation.

Current Clinical Trial Approaches

1. Immunotherapy Combinations (Platform Trials)

According to recent research, multi-site clinical trials are testing different immunotherapy combinations as first-line treatment for metastatic pancreatic cancer. These use a "platform trial" design, which is flexible—researchers can adapt treatments based on how patients respond.

What's being tested:

• Cohort A: Standard chemotherapy (nab-paclitaxel and gemcitabine) combined with two immunotherapy drugs (ipilimumab and nivolumab)
• Cohort B: Standard chemotherapy plus ipilimumab and hydroxychloroquine (a drug that may help the immune system fight cancer cells)

These trials are exploring which combinations work best and which patients benefit most from immunotherapy.

2. KRAS-Targeted Therapies

This is one of the most exciting developments. According to Dr. [removed] O'Reilly's 2024 expert webinar on novel pancreatic cancer therapies, KRAS mutations drive 87% of pancreatic cancers, and new targeted drugs are showing promise:

• RMC-6236 (Revolution Medicines): The first drug designed to directly inhibit all major forms of oncogenic KRAS. A global Phase III study is now open, comparing this drug to standard chemotherapy in patients with metastatic pancreatic cancer who've had one prior treatment.
• Additional KRAS-targeted drugs are in development with combinations of chemotherapy and immunotherapy

3. Metronomic Chemotherapy Combinations

Some trials are testing lower-dose chemotherapy given continuously over longer periods (called "metronomic therapy") combined with:

• Bevacizumab (a drug that blocks blood vessel growth to tumors)
• Standard chemotherapy drugs (5-FU, nab-paclitaxel, oxaliplatin, leucovorin)

The goal is to maintain cancer-fighting effects while reducing side effects.

4. FDA-Approved New Treatment (NALIRIFOX)

In 2024, the FDA approved NALIRIFOX—a combination of irinotecan liposome (ONIVYDE) with oxaliplatin, fluorouracil, and leucovorin for first-line treatment of metastatic pancreatic adenocarcinoma. This is the first new first-line treatment approved since 2013, and it has shown improved overall survival.

5. Targeted Therapies Based on Genetic Testing

If your tumor has specific genetic mutations, you may be eligible for targeted trials:

• BRCA mutations (BRCA1, BRCA2, PALB2): PARP inhibitors and chemotherapy combinations
• Homologous repair deficiency: PARP inhibitors and emerging immunotherapy combinations
• MTAP deletion: Approximately 15-20% of pancreatic cancer patients have this, with potential treatment implications being explored
• Other rare mutations: Genetic testing can identify additional targets

6. Emerging Immunotherapy Approaches

According to the 2024 expert guidance, researchers are exploring:

• Personalized neoantigen vaccines (customized cancer vaccines based on your tumor's unique mutations)
• CD40 agonists (drugs that activate the immune system)
• CD73 inhibitors (drugs that target immune system suppression)

---

How to Find Clinical Trials Right for You

According to NCCN Guidelines for Pancreatic Cancer, here are the best resources:

Recommended Trial Search Tools:

1. ClinicalTrials.gov - The official U.S. database of all clinical trials
2. Let's Win Trial Finder - Specifically designed for pancreatic cancer patients
3. Massive Bio - Free service that reviews your [ID removed] and recommends suitable trials
4. myTomorrows - Free service matching patients to relevant trials based on location and medical profile
5. Cancer Commons - Offers free second opinions and trial matching

Important Questions to Ask Your Doctor About Clinical Trials

According to NCCN Guidelines, ask:

1. Do you recommend that I consider a clinical trial for treatment?
2. How do I find clinical trials in which I can participate?
3. What are the treatments used in the clinical trial?
4. Has the treatment been used for other types of cancer?
5. What are the risks and benefits of this treatment?
6. What side effects should I expect and how will they be managed?
7. How long will I be in the clinical trial?
8. Will I be able to get other treatment if this doesn't work?
9. How will you know if the treatment is working?
10. Will the clinical trial cost me anything?

---

Why Genetic Testing Matters

Before exploring trials, molecular profiling of your tumor is essential. According to expert guidance, genetic testing should happen at your first appointment and should include:

• Germline testing (testing your normal cells for inherited mutations like BRCA)
• Somatic testing (testing your tumor cells for mutations like KRAS, BRCA, MTAP, and others)

This testing determines which targeted therapies and trials you're eligible for. Keep a copy of your molecular profiling report—it often doesn't automatically transfer between hospitals, and you'll need it for second opinions and trial applications.

---

Key Takeaway

The field of pancreatic cancer treatment is rapidly evolving. According to Dr. [removed] Strickler's 2024 expert webinar, we're entering an era of precision cancer medicine for pancreatic cancer, where treatments are matched to your tumor's specific genetic profile rather than using one-size-fits-all chemotherapy.

Your next steps:

1. Ask your oncologist about your tumor's genetic profile
2. Discuss whether clinical trials are appropriate for your situation
3. Use the trial finder tools above to identify options
4. Consider getting a second opinion from a major academic cancer center

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about which clinical trials may be appropriate for your specific situation.